HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stephane Ciblat Selected Research

mevociclib

1/2019Discovery and Characterization of SY-1365, a Selective, Covalent Inhibitor of CDK7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stephane Ciblat Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
01/2019
1Neoplasms (Cancer)
01/2019
1Ovarian Neoplasms (Ovarian Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

1mevociclibIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2019